Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The thalidomide story: a new chapter].

Eran Dolev

    Harefuah
    |April 17, 2003
    PubMed
    Summary
    This summary is machine-generated.

    Thalidomide, once banned for birth defects, is now used for cancer and inflammation due to its anti-angiogenic properties. It may also counteract blood vessel growth in the eyes following mustard gas exposure.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Adhesive bond strength of provisional screw-retained CAD-CAM crowns to titanium bases: An in vitro evaluation.

    Journal of prosthodontics : official journal of the American College of Prosthodontists·2026
    Same author

    Fluorescent Marker as a Tool to Improve Strategies to Control Contaminated Surfaces and Decrease Danger of Cross-Contamination in Dental Clinics, during and beyond the COVID-19 Pandemic.

    International journal of environmental research and public health·2023
    Same author

    Rethinking the Current "Stage-and-Wait" Paradigm.

    Prehospital and disaster medicine·2023
    Same author

    Effect of Silica-Modified Aluminum Oxide Abrasion on Adhesion to Dentin, Using Total-Etch and Self-Etch Systems.

    Polymers·2023
    Same author

    Zirconia CAD/CAM machining vibrations related to zirconia blank shape and initial digital nesting.

    International journal of computerized dentistry·2023
    Same author

    Assessing Children's Dental Age with Panoramic Radiographs.

    Children (Basel, Switzerland)·2022
    Same journal

    [Tennis Elbow Among Players].

    Harefuah·2026
    Same journal

    [Internal Medicine - My Mission].

    Harefuah·2026
    Same journal

    [Treatment of Morbid Obesity in Israel: GLP-1 Agonists Versus Bariatric Surgery - Clinical and Economic Aspects].

    Harefuah·2026
    Same journal

    [Baby steps: Post-operative Treatment Recommendations for Pediatric Tracheostomy in Israel].

    Harefuah·2026
    Same journal

    [Mastoiditis Caused by Fusobacterium Necrophorum: an Unusual Pathogen in a Well-Known Disease].

    Harefuah·2026
    Same journal

    [Cochlear Implantation in Single-Sided Deafness - Six Years of Follow-Up from Diagnosis and Consistent Use, Through Dedicated and Creative Auditory Learning, to the Development of Bilateral Central Processing Abilities].

    Harefuah·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Ophthalmology
    • Toxicology

    Background:

    • Thalidomide, initially withdrawn due to severe teratogenic effects, has been repurposed for its anti-angiogenic and immunomodulatory capabilities.
    • Current applications include novel treatments for malignant diseases and various inflammatory conditions.
    • Recent research indicates thalidomide's potential to inhibit corneal neovascularization, a complication arising from mustard gas exposure.

    Discussion:

    • The dual nature of thalidomide, with its historical risks and current therapeutic benefits, highlights the complex pharmacology of medications.
    • Its anti-angiogenic effect is crucial for treating conditions involving abnormal blood vessel growth, such as certain cancers and ocular neovascularization.
    • The potential to mitigate long-term effects of chemical warfare agents like mustard gas opens new therapeutic avenues.

    Related Experiment Videos

    Key Insights:

    • Thalidomide exhibits significant anti-angiogenic properties, impacting blood vessel formation.
    • The drug shows promise in treating mustard gas-induced corneal neovascularization.
    • Physicians must remain aware of the multifaceted effects and risks associated with medications like thalidomide.

    Outlook:

    • Further research into thalidomide's mechanisms could lead to optimized therapeutic strategies for ocular conditions and inflammatory diseases.
    • Investigating thalidomide's role in mitigating chemical injury sequelae may offer new hope for affected individuals.
    • The enduring story of thalidomide serves as a critical reminder of the imperative for comprehensive risk-benefit assessments in pharmacotherapy.